RSPH ETF (Invesco S&P 500 Equal Weight Health Care ETF) is managed by Invesco (US) with $730.5M in net assets. RSPH expense ratio is 0.40%, holding 62 positions across sectors including Health Care, Financials, Materials. Inception date: 2006-11-01.

RSPH performance shows a YTD return of 3.87%. The 1-year return is 10.31% and the 5-year return is 5.89%. RSPH dividend yield stands at 0.67%, paid quarterly.

RSPH top holdings include Moderna therapeutics (2.3%), Gilead Sciences Inc (2.0%), Viatris (2.0%), Merck & Company Inc (2.0%), Amgen Inc. (2.0%). View all RSPH holdings, sector breakdown, or dividend history.

RSPH can be compared against other funds using the overlap calculator or side-by-side comparison tool. RSPH alternatives are available via the screener, along with tax-loss harvesting opportunities.